On this week’s Tech Nation, Moira speaks with Margrethe Vestager, the Executive Vice President of the European Commission for “A Europe Fit for the Digital Age”.  Commissioner Vestager describes why the EU imposed fines on such digital giants as Google and Amazon, and the impact on the EU’s digital space since the Russian invasion of Ukraine. Then, University of the South Professor David George Haskell talks about sound – from the beginning of time on planet earth to the sounds in our teeming cities. His book is “Sounds Wild and Broken … Sonic Marvels, Evolution’s Creativity and the Crisis of Sensory Extinction”.

On this week’s Tech Nation, Moira speaks with Dr. Soren Kaplan talks about taking a look at your life experience to gain insight and action into your personal and business life. His book is “Experiential Intelligence: Harness the Power of Experience for Personal and Business Breakthroughs.” Then to a place in Alaska where no human has gone, much less conquered. Climber and rescuer, Michael Wejchert talks about “Hidden Mountains … Survival and Reckoning After a Climb Gone Wrong.”

On this week’s Tech Nation, Moira speaks with Dan Egan takes us on a world tour of phosphates – or would that be phosphorus? It’s best to pay attention. His book is “The Devil’s Element: Phosphorus and a World Out of Balance.” Then, Dr. Darren Kelly, the Founder and CEO of Certa Therapeutics in Melbourne, Australia, tells us about his many-decade scientific research which has led to a treatment for Schleroderma, now in advanced clinical trials. The results are worth noting.

On this week’s Tech Nation, Moira speaks with Dr. Andrew Steele in a FOLLOW-ON science-focused interview on the latest science behind ageing. His book is “Ageless … The New Science of Getting Older without Getting Old.” And then, an excerpt from Dr. Thomas Rando’s 2020 interview. A co-founder of Fountain Therapeutics, he tells us about their science and their efforts to potentially reverse the ageing process.

On this week’s Tech Nation, Moira speaks with Dr. Gabriella Kellerman joins me to talk about “TomorrowMind – Thriving at Work with Resilience, Creativity and Connection – Now and in an Uncertain Future”. The cover everything from Rapid Rapport to Psychological Safety in our work environment. Then … what is AI doing in biotech? Dr Vimal Mehta tells us how his company, BioXcel, used AT in drug discovery. One drug has already been approved, and there are more in the pipeline.

On this week’s Tech Nation, Moira speaks with Katherine Corcoran, the former Associate Press Bureau Chief for Mexico, talks about “In the Mouth of the Wolf: A Murder, a Coverup, and the True Cost of Silencing the Press”. She talks about the danger of being a journalist in Mexico, and one woman who paid the ultimate price. And following news of one biotech firm trying to bring back the dodo bird, we hear from Joe Hernandez from Blue Water Vaccines. His quest to develop a universal flu vaccine led him face-to-face – so to speak - with the Oxford dodo.

On this week’s Tech Nation, Moira speaks with Dr. Andrew Steele about “Ageless … The New Science of Getting Older without Getting Old.” Then, Tech Nation Health Chief Correspondent Dr. Daniel Kraft brings us uptodate on treating kidney disease and with heart transplants from genetically modified pigs in the news, kidneys are also being examined. Finally, with the West Coast of the United States under tsunami warning, former USGS scientist, Dr. Lucy Jones talks about “The Big Ones: How Natural Disasters Have Shaped Us”, and how we need to approach the aftermath.

On this week’s Tech Nation, Moira speaks with Chris Bailey about “How to Calm Your Mind … Finding Presence and Productivity in Anxious Times”. Science tells us that humans love dopamine, caffeine is essentially liquid stress, and burnout is more than being exhausted. Then, teaching our immune systems to recognize tumors in our own bodies and then eliminating them. Bolt Biotherapeutics’ CEO, Dr. Randy Schatzman, talks about the role of myeloid cells, and Bolt is studying nearly two dozen forms of HER2-related cancers.

On this week’s Tech Nation, developing antidepressants along with a test so when you take them, you know they will work. Dr. Amit Etkin, the founder and CEO Alto Neuroscience, explains how looking at each patient’s underlying biology is essential. Then Sir Rory Collins, the Principal Investigator of the UK BioBank. With data from half a million people, it has served 30,000 scientists around the world, giving special support to young researchers and scientists in emergent countries.

On this week’s Tech Nation, James Vincent about his book, “Beyond Measure: The Hidden History of Measurement from Cubits to Quantum Constants”, and our age-old propensity as humans … to measure things. Then Dr. Rob Ross from Surface Oncology tells us why the first generation of immuno-oncology drugs only worked on 15% of cancer patients, and how Surface Oncology is tackling the other 85%. Their Phase 2 trials in lung cancer and liver cancer are recruiting now.